IP Library › Assignment 052983/0444
Patent Assignment
Reel/Frame 052983/0444

Assignment of Assignor's Interest

Recorded: 2020-06-18 Pages: 4
Assignor
NIAZI, KAYVAN
Executed: 2020-06-11
Assignee
IMMUNITYBIO, INC.
9920 JEFFERSON BLVD., CULVER CITY, CALIFORNIA, 90232
Covered Property (1)
Replication-Defective Adenoviruses Comprising Nucleic Acids Encoding Sars-Cov-2 S Glycoprotein and Modified N Protein Comprising an Endosomal Targeting Sequence
Application: 16/883,263 →
Publication: US 2021/0283245
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 18, 2020
From: KING, THOMAS
To: GLOBEIMMUNE, INC.
Reel/Frame 052983/0401 →
Change of Name Sep 8, 2021
From: IMMUNITYBIO, INC.
To: NANTCELL, INC.
Reel/Frame 057528/0064 →
Assignment of Assignor's Interest Oct 20, 2022
From: GLOBEIMMUNE, INC.
To: NANT HOLDINGS IP, LLC
Reel/Frame 061487/0185 →
Assignment of Assignor's Interest Oct 26, 2022
From: GLOBEIMMUNE, INC.
To: NANTCELL, INC.
Reel/Frame 061545/0318 →
Security Interest Jan 2, 2024
From: IMMUNITYBIO, INC.; NANTCELL, INC.; RECEPTOME, INC.; VBC HOLDINGS LLC
To: INFINITY SA LLC, AS PURCHASER AGENT
Reel/Frame 066179/0074 →